Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Anesthesia and Analgesia

Volume  4, Issue 2, April - June 2017, Pages 532-536
 

Original Article

Dexmedetomidine an Adjuvant in Anaesthesia for Functional Endoscopic Sinus Surgery (FESS)

Vijayarekha Koti*, Sharathbabu Chevuri*, Syed Abdul Wasiq**, Bashirunnisa**

*Associate Professor **Post Graduate Student, Department of Anaesthesiology, Deccan College of Medical Sciences, Hyderabad.

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.4217.28

Abstract

Introduction: Dexmedetomidine can provide controlled hypotension, analgesia, and sedation. The present study aimed to evaluate advantages of dexmedetomidine as an adjuvant in anesthesia fo FESS (Functional Endoscopic Sinus Surgery). Materials and Methods: Study was conducted in 50 patients form April-2015 to March -2016 after obtaining approval from ethical committee and informed consent from the patients. who were ASA grade I/II, aged between 18-55years scheduled for FESS. Patients were randomly allocated into two groups of Group D (n=25) which received injection Dexmeditomidine as loading dose of 1 mcg/kg intravenously followed by maintenance infusion of 0.6mcg/kg intravenously and Group NS (n=25) received normal saline in similar volume. Results: The baseline mean systolic blood pressure was lower during surgery in patients of group D, but not statistically significant . At the end of surgery and after recovery, blood pressure is significantly lower in group D (114± 11 vs. 131 ± 9 mmHg; P < 0.05). Baseline values of the mean heart rate intraoperatively was significantly reduced compared with the baseline value in group D (P < 0.05), After extubation, the heart rate was found to be higher in patients of the GroupNS (98 ± 4 vs. 86 ± 3 beats/ minutes). Blood losses were lower in group D as compared to group NS ( p= 0.03 ).The Visual Analogue Scale (VAS) scores in the immediate postoperative periods were also significantly lower in the group D ( p =0.03 ). The only side effect noted was bradycardia in 3 patients in group D. Isoflurane requirement was also reduced in the maintenance of anaesthesia. Conclusion: Dexmedetomidine as an adjuvant for hypotensive anaesthesia is effective and decreases bleeding thus providing relatively bloodless field during FESS.


Keywords : Sinusitis; D e x m e d e t o m i d i n e ; Hypotensive Effect; Anesthesia Adjuvants.
Corresponding Author : Vijayarekha Koti, Associate Professor, Department of Anaesthesiology, Deccan College of Medical Sciences, Hyderabad, Telangana 500058.